Abstract:Background The hemodynamics and oxygenation severely fluctuated during the off-pump coronary artery bypass grafting ( OPCABG). This study aimed at investigating whether or not nicardipine combined with esmolol (1: 10) can maintain systemic and tissue oxygenation during OPCABG.Methods Twenty patients scheduled for OPCABG were divided ramdomly into Group nicardipine (N) and Group nitroglycerine (X) respectively combined with esmolol (E) (Dosage ratio: 1 to 10) (Group N + E and Group X + E) with 10 patients in each group. The mixed solution of N + E or X + E were titrated to maintain mean arterial blood pressure between 70 and 80 mmHg following anesthesia induction. The variables of hemodynamics, arterial blood lactate content (Lac) and gastric intramucosal partial pressure of carbon dioxide were measured at the following time points: after induction of anesthesia (T-1), pre-revascularization (T-2), grafting of left anterior descending (T-3), right coronary descending (T-4) and left coronary circumflexus branches (T-5), post-revascularization (T-6), the end of operation (T-7). The delivery of oxygen (DO2) consumption of oxygen (VO2) and gastric intramucosal pH(pHi) were calculated.Results The cardiac index (CI) in Group N + E was significantly increased (P < 0.05) as compared with T-1 during OPCABG, while it was mildly decreased in Group X + E. The stroke volumes at T,, T, in Group N + E and at T-3 - T-6 in Group X + E were significantly decreased ( P < 0.05). The systemic vascular resistance indices in Group N + E were significantly decreased as compared with T-1 (P < 0.05). The heart rates in these two Groups were significantly elevated intraoperatively P < 0. 05 The DO2 after the infusion of N + E was significantly increased ( P < 0.05) or leveled to T-1, and the Lac were within the normal range. But the DO2 in Group X + E was decreased throughout the procedure, reaching significant level at T-5 ( P < 0.05), and the Lac was significantly increased beyond normal range (P < 0.05). The pHi in Group N + E was maintained above 7.35 during OPCABG, while it was less than 7.35 from T-4 to T-7 in Group X + E.Conclusion Nicardipine combined with esmolol (1 : 10) regimen may maintain systemic and tissue oxygenation during OPCABG.

Combined using nitric oxide and milrinone stabilizes pulmonary hemodynamics after Fontan procedure

Inhaled Nitric Oxide in Preterm and Term Neonates with Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension

Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in infant rats meconium aspiration lung injury

Intravenous prostaglandin E1 versus inhaled nitric oxide in management severe pulmonary hypertension associated with congenital heart defects after cardiac surgery

First-year outcomes of very low birth weight preterm singleton infants with hypoxemic respiratory failure treated with milrinone and inhaled nitric oxide (iNO) compared to iNO alone: A nationwide retrospective study

Inhalation of Nitric Oxide in Congenital Heart Defects Associated with Pulmonary Hypertension

Use of inhaled nitric oxide in submassive intermediate-risk pulmonary embolism: a single-centre experience

Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella

Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial

Comparison of Inhaled Nitric Oxide and Iloprost in Infants with Moderate or Severe Pulmonary Hypertension Af-Ter Cardiac Surgery:A Prospective Randomized Trial

Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury

Inhaled nitric oxide reduces the intrapulmonary shunt to ameliorate severe hypoxemia after acute type A aortic dissection surgery

Initial Clinical Impact of Inhaled Nitric Oxide Therapy for Refractory Hypoxemia Following Type A Acute Aortic Dissection Surgery.

Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case Reports

Inhaled Nitric Oxide Therapy for Hypoxic Respiratory Failure in Neonates

No Inhalation in Combination with High Frequency Ventilation Treatment in the Treatment of Neonatal Severe Respiratory Failure

The efficacy of nitric oxide inhalation and magnesium sulfate infusion in the treatment of neonatal pulmonary hypertension

Is One Better than the Others?

Effect of Nicardipine Combined with Esmolol on Systemic and Tissue Oxygenation During Off-Pump Coronary Artery Bypass Grafting Surgery

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure

Transcatheter occlusion of venovenous collaterals in the total cavopulmonary Fontan circulation